WuXi Signs Testing PactBy
WuXi PharmaTech, a contract research organization, and Lee’s Pharmaceutical Holdings Ltd., a research-based biopharmaceutical company headquartered in Hong Kong, have signed an agreement whereby WuXi’s Laboratory Testing Division (LTD) will be the exclusive supplier of laboratory testing services for Lee’s Pharmaceutical.
These services will include LTD’s entire portfolio of discovery and investigational new drug/new drug applicatio package services, including chemistry analytical services, in vitro and in vivo biology, oncology, immunology, in vitro ADME (absorption, distribution, metabolism, and excretion), pharmacokinetic/pharmacodynamic studies, toxicology, and clinical bioanalysis. LTD will provide dedicated program management, streamline project coordination across WuXi, and allocate the necessary resources and R&D development efforts for Lee’s Pharm programs.
Source: WuXi PharmaTech